These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9833134)

  • 21. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
    Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation.
    Böhm M; Diet F; Feiler G; Kemkes B; Kreuzer E; Weinhold C; Erdmann E
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):726-32. PubMed ID: 2467092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations.
    Danielsen W; v der Leyen H; Meyer W; Neumann J; Schmitz W; Scholz H; Starbatty J; Stein B; Döring V; Kalmár P
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):171-3. PubMed ID: 2475709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium.
    Flesch M; Schwinger RH; Schiffer F; Frank K; Südkamp M; Kuhn-Regnier F; Arnold G; Böhm M
    Circulation; 1996 Sep; 94(5):992-1002. PubMed ID: 8790037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium.
    Pieske B; Maier LS; Bers DM; Hasenfuss G
    Circ Res; 1999 Jul; 85(1):38-46. PubMed ID: 10400909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency dependent force generation correlates with sarcoplasmic calcium ATPase activity in human myocardium.
    Frank K; Bölck B; Bavendiek U; Schwinger RH
    Basic Res Cardiol; 1998 Oct; 93(5):405-11. PubMed ID: 9833153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the action potential prolonging and positive inotropic activity of DPI 201-106 and BDF 9148 in human ventricular myocardium.
    Hoey A; Amos GJ; Ravens U
    J Mol Cell Cardiol; 1994 Aug; 26(8):985-94. PubMed ID: 7799453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of different inotropic interventions on myocardial function in the developing rabbit heart.
    Schiffmann H; Flesch M; Häuseler C; Pfahlberg A; Böhm M; Hellige G
    Basic Res Cardiol; 2002 Jan; 97(1):76-87. PubMed ID: 11998979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive inotropic effects in isolated ventricular myocardium from non-failing and terminally failing human hearts.
    Näbauer M; Böhm M; Brown L; Diet F; Eichhorn M; Kemkes B; Pieske B; Erdmann E
    Eur J Clin Invest; 1988 Dec; 18(6):600-6. PubMed ID: 2465159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium cycling proteins and force-frequency relationship in heart failure.
    Hasenfuss G; Reinecke H; Studer R; Pieske B; Meyer M; Drexler H; Just H
    Basic Res Cardiol; 1996; 91 Suppl 2():17-22. PubMed ID: 8957539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cyclopiazonic acid on the force-frequency relationship in human nonfailing myocardium.
    Schwinger RH; Brixius K; Bavendiek U; Hoischen S; Müller-Ehmsen J; Bölck B; Erdmann E
    J Pharmacol Exp Ther; 1997 Oct; 283(1):286-92. PubMed ID: 9336335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence against a role of nitric oxide in the indirect negative inotropic-effect of M-cholinoceptor stimulation in human ventricular myocardium.
    Kilter H; Lenz O; La Rosée K; Flesch M; Schwinger RH; Mädge M; Kuhn-Regnier F; Böhm M
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):308-12. PubMed ID: 8584047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of cardiac glycosides in human myocardium with and without "downregulated" beta-adrenoceptors.
    Schwinger RH; Böhm M; Erdmann E
    J Cardiovasc Pharmacol; 1990 May; 15(5):692-7. PubMed ID: 1692927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of isomazole on force of contraction and phosphodiesterase isoenzymes I-IV in nonfailing and failing human hearts.
    Bethke T; Klimkiewicz A; Kohl C; von der Leyen H; Mehl H; Mende U; Meyer W; Neumann J; Schmitz W; Scholz H
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):386-97. PubMed ID: 1720839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased functional importance of the Na,Ca-exchanger in contracting failing human myocardium but unchanged activity in isolated vesicles.
    Diedrichs H; Frank K; Schneider CA; Burst V; Hagemeister J; Zobel C; Müller-Ehmsen J
    Int Heart J; 2007 Nov; 48(6):755-66. PubMed ID: 18160767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Halothane restores the altered force-frequency relationship in failing human myocardium.
    Schmidt U; Schwinger RH; Böhm M
    Anesthesiology; 1995 Jun; 82(6):1456-62. PubMed ID: 7793659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy.
    Schwinger RH; Böhm M; Erdmann E
    Am Heart J; 1992 Jan; 123(1):116-28. PubMed ID: 1309621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of propofol on the contractility of failing and nonfailing human heart muscles.
    Sprung J; Ogletree-Hughes ML; McConnell BK; Zakhary DR; Smolsky SM; Moravec CS
    Anesth Analg; 2001 Sep; 93(3):550-9. PubMed ID: 11524317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
    Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
    Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.